Vertex Pharmaceuticals: JP Morgan raises target price to $570 from $560
VRTX•JP Morgan raised its target price for Vertex Pharmaceuticals to $570 from $560.
Related News
Multi-cancer screening draws investment as clinical hurdles remain
ABT•
Aramco CEO says firm exploring new export routes, ready to ramp up production
USO•
KBW cuts Opendoor Technologies' target price to $1.75 from $2.65
OPEN•
CommBank forecasts record 14% peak-to-trough fall in Australian home prices
CMWAY•
SBA Communications target price raised to $239 from $229 by TD Cowen
SBAC•